Delineation of the GPR15 receptor-mediated Gα protein signalling profile in recombinant mammalian cells

Yufang Deng, Ee Von Moo, Claudia Victoria Pérez Almería, Patrick R. Gentry, Line Vedel, Jesper M. Mathiesen, Hans Bräuner-Osborne*

*Corresponding author for this work

Research output: Contribution to JournalArticleAcademicpeer-review

Abstract

The GPR15 receptor is a G protein-coupled receptor (GPCR), which is activated by an endogenous peptide GPR15L(25–81) and a C-terminal peptide fragment GPR15L(71–81). GPR15 signals through the Gi/o pathway to decrease intracellular cyclic adenosine 3′,5′-monophosphate (cAMP). However, the activation profiles of the GPR15 receptor within Gi/o subtypes have not been examined. Moreover, whether the receptor can also couple to Gs, Gq/11 and G12/13 is unclear. Here, GPR15L(25–81) and GPR15L(71–81) are used as pharmacological tool compounds to delineate the GPR15 receptor-mediated Gα protein signalling using a G protein activation assay and second messenger assay conducted on living cells. The results show that the GPR15 receptor preferentially couples to Gi/o rather than other pathways in both assays. Within the Gi/o family, the GPR15 receptor activates all the subtypes (Gi1, Gi2, Gi3, GoA, GoB and Gz). The Emax and activation rates of Gi1, Gi2, Gi3, GoA and GoB are similar, whilst the Emax of Gz is smaller and the activation rate is significantly slower. The potencies of both peptides toward each Gi/o subtype have been determined. Furthermore, the GPR15 receptor signals through Gi/o to inhibit cAMP accumulation, which could be blocked by the application of the Gi/o inhibitor pertussis toxin.

Original languageEnglish
Pages (from-to)104-113
Number of pages10
JournalBasic and Clinical Pharmacology and Toxicology
Volume131
Issue number2
Early online date5 May 2022
DOIs
Publication statusPublished - Aug 2022

Bibliographical note

Funding Information:
This project was funded by the China Scholarship Council (Grant #201907940002 to Y.D.), the Novo Nordisk Foundation (Grants NNF17OC0028412 and NNF19OC0057730 to H.B.‐O.), the Carlsberg Foundation (Grant CF20‐0248 to H.B.‐O.) and the European Union's Horizon2020 research and innovation program under the Marie Sklodowska‐Curie grant agreement No 846827 (E.V.M.)

Funding Information:
This project was funded by the China Scholarship Council (Grant #201907940002 to Y.D.), the Novo Nordisk Foundation (Grants NNF17OC0028412 and NNF19OC0057730 to H.B.-O.), the Carlsberg Foundation (Grant CF20-0248 to H.B.-O.) and the European Union's Horizon2020 research and innovation program under the Marie Sklodowska-Curie grant agreement No 846827 (E.V.M.)

Publisher Copyright:
© 2022 The Authors. Basic & Clinical Pharmacology & Toxicology published by John Wiley & Sons Ltd on behalf of Nordic Association for the Publication of BCPT (former Nordic Pharmacological Society).

Funding

This project was funded by the China Scholarship Council (Grant #201907940002 to Y.D.), the Novo Nordisk Foundation (Grants NNF17OC0028412 and NNF19OC0057730 to H.B.‐O.), the Carlsberg Foundation (Grant CF20‐0248 to H.B.‐O.) and the European Union's Horizon2020 research and innovation program under the Marie Sklodowska‐Curie grant agreement No 846827 (E.V.M.) This project was funded by the China Scholarship Council (Grant #201907940002 to Y.D.), the Novo Nordisk Foundation (Grants NNF17OC0028412 and NNF19OC0057730 to H.B.-O.), the Carlsberg Foundation (Grant CF20-0248 to H.B.-O.) and the European Union's Horizon2020 research and innovation program under the Marie Sklodowska-Curie grant agreement No 846827 (E.V.M.)

FundersFunder number
European Union's Horizon2020 research and innovation program
Horizon 2020 Framework Programme
H2020 Marie Skłodowska-Curie Actions846827
CarlsbergfondetCF20‐0248
China Scholarship Council201907940002
Novo Nordisk FondenNNF17OC0028412, NNF19OC0057730

    Keywords

    • BRET
    • GPR15
    • Gα protein
    • second messenger
    • signalling

    Fingerprint

    Dive into the research topics of 'Delineation of the GPR15 receptor-mediated Gα protein signalling profile in recombinant mammalian cells'. Together they form a unique fingerprint.

    Cite this